Millipore Sigma Vibrant Logo

444244 MMP-2 Inhibitor I - CAS 10335-69-0 - Calbiochem

The MMP-2 Inhibitor I, also referenced under CAS 10335-69-0, controls the biological activity of MMP-2. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: cis-9-Octadecenoyl-N-hydroxylamide, Oleoyl-N-hydroxylamide, OA-Hy

Primary Target: MMP-2
View Products on Sigmaaldrich.com
444244
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
10335-69-0C₁₈H₃₅NO₂

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
444244-10MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 10 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA cell-permeable, potent inhibitor of MMP-2 that acts in a dose-dependent manner (Ki = 1.7 µM).
      Catalogue Number444244
      Brand Family Calbiochem®
      Synonymscis-9-Octadecenoyl-N-hydroxylamide, Oleoyl-N-hydroxylamide, OA-Hy
      References
      ReferencesBerton, A., et. al. 2001. J. Biol. Chem. 276, 20458.
      Emonard, H., et al. 1999. Ann. N.Y. Acad. Sci. 878, 647.
      Product Information
      CAS number10335-69-0
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₁₈H₃₅NO₂
      Chemical formulaC₁₈H₃₅NO₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetMMP-2
      Primary Target K<sub>i</sub>1.7 mM
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsUnstable in solution; reconstitute just prior to use.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      444244-10MG 04055977186468

      Documentation

      MMP-2 Inhibitor I - CAS 10335-69-0 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      MMP-2 Inhibitor I - CAS 10335-69-0 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      444244

      Références bibliographiques

      Aperçu de la référence bibliographique
      Berton, A., et. al. 2001. J. Biol. Chem. 276, 20458.
      Emonard, H., et al. 1999. Ann. N.Y. Acad. Sci. 878, 647.

      Citations

      Titre
    • Anthony R. White, et al. (2006) Degradation of the alzheimer disease amyloid -peptide by metal-dependent up-regulation of metalloprotease activity. journal of Biological Chemistry 281, 17670-17680.
    • Michelle K.Y. Siu and C. Yan Cheng. (2004) Interactions of proteases, protease inhibitors, and the β1 integrin/laminin γ3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Biology of Reproduction 70, 945-964.
    • Feng Zheng, et al. (2004) Development of albuinuria and glomerular lesions in normoglycemic B6 recepients of db/db mice bone marrow. Diabetes 53, 2420-2427.
      		•
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision14-November-2023 JSW
      Synonymscis-9-Octadecenoyl-N-hydroxylamide, Oleoyl-N-hydroxylamide, OA-Hy
      DescriptionPotent inhibitor of MMP-2 (gelatinase A). Inhibits MMP-2 in a dose dependent manner (Ki = 1.7 µM)
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number10335-69-0
      Chemical formulaC₁₈H₃₅NO₂
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (2 mg/ml) or Ethanol (3 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsUnstable in solution; reconstitute just prior to use.
      Toxicity Standard Handling
      ReferencesBerton, A., et. al. 2001. J. Biol. Chem. 276, 20458.
      Emonard, H., et al. 1999. Ann. N.Y. Acad. Sci. 878, 647.
      Citation
    • Anthony R. White, et al. (2006) Degradation of the alzheimer disease amyloid -peptide by metal-dependent up-regulation of metalloprotease activity. journal of Biological Chemistry 281, 17670-17680.
    • Michelle K.Y. Siu and C. Yan Cheng. (2004) Interactions of proteases, protease inhibitors, and the β1 integrin/laminin γ3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Biology of Reproduction 70, 945-964.
    • Feng Zheng, et al. (2004) Development of albuinuria and glomerular lesions in normoglycemic B6 recepients of db/db mice bone marrow. Diabetes 53, 2420-2427.
      		•